Ocular myasthenia gravis;
Showing 1 - 25 of 2,736
Ocular Myasthenia Gravis Trial in Xi'an (Symptomatic Treatment, Steroids, Immunosuppressive Agents( azathioprine, tacrolimus,
Recruiting
- Ocular Myasthenia Gravis
- Symptomatic Treatment, Steroids, Immunosuppressive Agents( azathioprine, tacrolimus, Mycophenolate Mofetil)
-
Xi'an, Shaanxi, ChinaTangdu Hospotal
Aug 16, 2022
Myasthenia Gravis Trial in Guangzhou (Body fluid diagnosis)
Enrolling by invitation
- Myasthenia Gravis
- Body fluid diagnosis
-
Guangzhou, Guangdong, ChinaFirst Affiliated Hospital of Jinan University
May 25, 2023
Ocular Myasthenia Gravis, Cytomegalovirus Infections Trial in Guangzhou (Serum acetylcholine receptor antibody, erythrocyte
Recruiting
- Ocular Myasthenia Gravis
- Cytomegalovirus Infections
- Serum acetylcholine receptor antibody, erythrocyte deposition rate, hypersensitive C protein, neostigmine test,thymus CT, low frequency repeated nerve stimulation
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital of Jinan University
Oct 20, 2021
Myasthenia Gravis, Ocular Myasthenia Gravis Trial in Beirut (Apraclonidine Hcl 0.5% Oph Soln)
Completed
- Myasthenia Gravis
- Ocular Myasthenia Gravis
- Apraclonidine Hcl 0.5% Oph Soln
-
Beirut, LebanonAmerican University of Beirut Medical Center
Sep 6, 2021
Predictors and Prognostic Factors of Myasthenia Gravis Outcome
Recruiting
- Myasthenia Gravis
- +11 more
- Drug treatment of myasthenia gravis and treatment of crisis
-
Assiut, EgyptAssiut University
Feb 22, 2022
VDR Gene Polymorphisms and Risk and Features of MG in Han
Completed
- Myasthenia Gravis, Ocular
- Gene Polymorphism
- Genotype analysis for VDR rs1544410, rs2228570, rs731236, and rs7975232 polymorphisms
-
Beijing, ChinaBeijing Tongren Hospital
May 15, 2022
Ocular Mysathenia Gravis Generalization
Completed
- Ocular Myasthenia Gravis
- Use of nomogram for predictions of Ocular Mysathenia Gravis generalization
-
Paris, FranceAntoine GUEGUEN
Dec 8, 2020
Generalized Myasthenia Gravis Trial (rozanolixizumab)
Not yet recruiting
- Generalized Myasthenia Gravis
- (no location specified)
Nov 28, 2023
Myasthenia Gravis, Ocular Trial in Zurich (Ocular vestibular evoced myogenic potentials)
Completed
- Myasthenia Gravis, Ocular
- Ocular vestibular evoced myogenic potentials
-
Zurich, SwitzerlandUniversity Hospital Zurich, Ophthalmology/Neurology Department
Jan 8, 2021
Myasthenia Gravis Trial in Uppsala (Physical activity, Sleep hygiene)
Recruiting
- Myasthenia Gravis
- Physical activity
- Sleep hygiene
-
Uppsala, SwedenUppsala University
Aug 14, 2023
Myasthenia Gravis Trial in Toronto (subcutaneous immunoglobulin (SCIG), intravenous immunoglobulin + subcutaneous immunoglobulin
Recruiting
- Myasthenia Gravis
- subcutaneous immunoglobulin (SCIG)
- intravenous immunoglobulin + subcutaneous immunoglobulin (SCIG)
-
Toronto, Ontario, CanadaUniversity Health Network
Nov 21, 2022
Myasthenia Gravis Trial in Leiden (Pyridostigmine, Amifampridine (base) with modified release, Placebo)
Recruiting
- Myasthenia Gravis
- Pyridostigmine
- +2 more
-
Leiden, South-Holland, NetherlandsLeiden University Medical Center
Jun 16, 2023
Sensitivity of Repetitive Nerve Stimulation Performed in Evening
Recruiting
- Myasthenia Gravis
-
Kraków, Lesser Poland, PolandJagiellonian University Medical College, Department of Neurology
Aug 13, 2022
Myasthenia Gravis, Generalized Trial in Roma (Rituximab, Placebo)
Recruiting
- Myasthenia Gravis, Generalized
- Rituximab
- Placebo
-
Roma, ItalyPoliclinico A. Gemelli IRCCS
May 25, 2023
A Prospective Cohort Study of Myasthenia Gravis in China
Recruiting
- Myasthenia Gravis
- Steroid Drug
- Withdraw all immunosuppresants
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Aug 17, 2023
Myasthenia Gravis Trial in New Haven (Blood Sample Draw)
Recruiting
- Myasthenia Gravis
- Blood Sample Draw
-
New Haven, ConnecticutYale-New Haven Hospital
Nov 14, 2022
Myasthenia Gravis and Psyche
Completed
- Myasthenia Gravis
-
Berlin, GermanyNeuroCure Clinical Research Center (NCRC), Charité
Jan 6, 2023
Myasthenia Gravis, Generalized Myasthenia, AChR Myasthenia Gravis Trial in Chicago (CNP-106, Placebo)
Not yet recruiting
- Myasthenia Gravis
- +3 more
- CNP-106
- Placebo
-
Chicago, IllinoisResearch Site
Oct 30, 2023
Vitaccess Real MG Registry
Not yet recruiting
- Myasthenia Gravis
-
Oxford, Oxfordshire, United KingdomVitaccess Ltd
Sep 26, 2023
Measures Pilot Trial for Telehealth in Myasthenia Gravis
Completed
- Myasthenia Gravis
- Telehealth
-
New Haven, Connecticut
- +4 more
Jun 14, 2023
Myasthenia Gravis Trial in Hangzhou (CD19 CAR-T cells injection)
Recruiting
- Myasthenia Gravis
- CD19 CAR-T cells injection
-
Hangzhou, Zhejiang, ChinaThe first affiliated hospital of medical college of zhejiang uni
Apr 12, 2023
Generalized Myasthenia Gravis Trial in Columbia (Whole-body Electrical Muscle Stimulation Exercise)
Active, not recruiting
- Generalized Myasthenia Gravis
- Whole-body Electrical Muscle Stimulation Exercise
-
Columbia, MissouriNextGen Precision Health Building, Clinical Translational Scienc
Sep 26, 2023
Myasthenia Gravis, Myasthenia Gravis, Juvenile Form, Myasthenia Gravis, Generalized Trial in Japan, Netherlands, United States
Active, not recruiting
- Myasthenia Gravis
- +2 more
-
Los Angeles, California
- +15 more
Aug 1, 2022
Generalized Myasthenia Gravis Trial (Rozanolixizumab)
Not yet recruiting
- Generalized Myasthenia Gravis
- (no location specified)
Jan 4, 2023